Funded Tech Companies
Zucara Therapeutics
Wondering who backed Zucara Therapeutics? Sanofi Ventures, Perceptive Xontogeny Venture Fund and private investors put venture money into this biopharmaceutical company.
Company Overview
Company Name
Zucara Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
661 University Ave. 1300
Toronto ON, M5G 0B7
Canada
Toronto ON, M5G 0B7
Canada
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type 1 diabetes is not properly controlled.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/12/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Michael Riddell
Chief Executive Officer
Michael Midmer
Chief Scientific Officer
Richard Liggins
VP - Regulatory Affairs
Susan Peers
Company Investors
- Sanofi Ventures
- Perceptive Xontogeny Venture Fund
- Perceptive Advisors (Chris Garabedian)
- Leona M. and Harry B. Helmsley Charitable Trust (Ben Williams)
- JDRF T1D Fund
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs